| Year |
Citation |
Score |
| 2020 |
Hoban DB, Shrigley S, Mattsson B, Breger LS, Jarl U, Cardoso T, Nelander Wahlestedt J, Luk KC, Björklund A, Parmar M. Impact of α-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized α-synuclein rat model of PD. Proceedings of the National Academy of Sciences of the United States of America. PMID 32541058 DOI: 10.1073/Pnas.2001305117 |
0.55 |
|
| 2018 |
Quintino L, Avallone M, Brännstrom E, Kavanagh P, Lockowandt M, Garcia Jareño P, Breger LS, Lundberg C. GDNF-mediated rescue of the nigrostriatal system depends on the degree of degeneration. Gene Therapy. PMID 30531868 DOI: 10.1038/S41434-018-0049-0 |
0.679 |
|
| 2018 |
Quintino L, Namislo A, Davidsson M, Breger LS, Kavanagh P, Avallone M, Elgstrand-Wettergren E, Isaksson C, Lundberg C. Destabilizing Domains Enable Long-Term and Inert Regulation of GDNF Expression in the Brain. Molecular Therapy. Methods & Clinical Development. 11: 29-39. PMID 30324128 DOI: 10.1016/J.Omtm.2018.08.008 |
0.721 |
|
| 2018 |
Fieblinger T, Zanetti L, Sebastianutto I, Breger LS, Quintino L, Lockowandt M, Lundberg C, Cenci MA. Striatonigral neurons divide into two distinct morphological-physiological phenotypes after chronic L-DOPA treatment in parkinsonian rats. Scientific Reports. 8: 10068. PMID 29968767 DOI: 10.1038/S41598-018-28273-5 |
0.715 |
|
| 2017 |
Thakur P, Breger LS, Lundblad M, Wan OW, Mattsson B, Luk KC, Lee VMY, Trojanowski JQ, Björklund A. Modeling Parkinson's disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain. Proceedings of the National Academy of Sciences of the United States of America. PMID 28900002 DOI: 10.1073/Pnas.1710442114 |
0.559 |
|
| 2016 |
Breger LS, Kienle K, Smith GA, Dunnett SB, Lane EL. Influence of chronic L-DOPA treatment on immune response following allogeneic and xenogeneic graft in a rat model of Parkinson's disease. Brain, Behavior, and Immunity. PMID 27864045 DOI: 10.1016/J.Bbi.2016.11.014 |
0.73 |
|
| 2016 |
Chtarto A, Humbert-Claude M, Bockstael O, Das AT, Boutry S, Breger LS, Klaver B, Melas C, Barroso-Chinea P, Gonzalez-Hernandez T, Muller RN, DeWitte O, Levivier M, Lundberg C, Berkhout B, et al. A regulatable AAV vector mediating GDNF biological effects at clinically-approved sub-antimicrobial doxycycline doses. Molecular Therapy. Methods & Clinical Development. 5: 16027. PMID 27069954 DOI: 10.1038/mtm.2016.27 |
0.67 |
|
| 2016 |
Breger L, Wettergren EE, Quintino L, Lundberg C. Regulated Gene Therapy. Methods in Molecular Biology (Clifton, N.J.). 1382: 57-66. PMID 26611578 DOI: 10.1007/978-1-4939-3271-9_4 |
0.691 |
|
| 2015 |
Humbert-Claude M, Chtarto A, Bockstael O, Breger L, Das A, De Witte O, Berkhout B, Lundberg C, Levivier M, Tenenbaum L. Toward the Pharmacological Control of Gene Transfer-Mediated Intracerebral Neurotrophic Factor Administration Journal of Neurological Surgery Part a: Central European Neurosurgery. 76. DOI: 10.1055/s-0035-1564510 |
0.634 |
|
| 2013 |
Breger LS, Lane EL. L-DOPA and graft-induced dyskinesia: different treatment, same story? Experimental Biology and Medicine (Maywood, N.J.). 238: 725-32. PMID 23828589 DOI: 10.1177/1535370213488478 |
0.785 |
|
| 2013 |
Breger LS, Dunnett SB, Lane EL. Comparison of rating scales used to evaluate L-DOPA-induced dyskinesia in the 6-OHDA lesioned rat. Neurobiology of Disease. 50: 142-50. PMID 23072976 DOI: 10.1016/J.Nbd.2012.10.013 |
0.76 |
|
| 2012 |
Smith GA, Breger LS, Lane EL, Dunnett SB. Pharmacological modulation of amphetamine-induced dyskinesia in transplanted hemi-parkinsonian rats. Neuropharmacology. 63: 818-28. PMID 22722025 DOI: 10.1016/J.Neuropharm.2012.06.011 |
0.73 |
|
| Show low-probability matches. |